New FLEXISEQ gel - formulated to combat joint pain associated with osteoarthritis.
FLEXISEQ has been classified by UK, European and other regulators as a medical device and not a drug and does not contain any pharmaceutically active ingredients which can interfere with other medication or treatment.
Visit www.flexiseq.com for more details.
Read the FLEXISEQ patient leaflet (PDF 3.3 MB).
An independent assessment of the effectiveness and safety of FLEXISEQ is also available.
The manufacturer of FLEXISEQ, Pro Bono Bio, is supporting Arthritis Research UK through its humanitarian programme.
Only available in the UK.